13G Filing: Knoll Capital Management Raises Stake in Synthetic Biologics, Inc. (SYN)

Fred Knoll's Knoll Capital Management has issued three Form 13G filings today, with one of them being on Synthetic Biologics Inc (NYSEMKT:SYN), which ranked as the investment firm's third-largest holding...... (read more)